SYRS - Syros Pharmaceuticals (SYRS) CEO Dr. Nancy Simonian on Q4 2018 Results - Earnings Call Transcript
Q4 2018 Earnings Conference Call
March 7, 2019 08:30 AM ET
Company Participants
Naomi Aoki - VP, Corporate Communications and IR
Dr. Nancy Simonian - CEO
Dr. David Roth - Chief Medical Officer
Joe Ferra - CFO
Conference Call Participants
Phil Nadeau - Cowen and Company
Ted Tenthoff - Piper Jaffray
Mark Breidenbach - Oppenheimer
Jotin Marango - ROTH Capital Partners
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Q4 2018 Syros Pharmaceuticals Incorporated Earnings Conference Call. [Operator Instructions]
I would now like to introduce your host for today’s